TABLE 2.

Factors related predicting the continuation of the apomorphine treatment at the end of APOMORPHEE study

Factors predicting apomorphine continuation	β	S.E	P‐value	OR (95% CI)
Insomnia severity index (ISI)	0.215	0.122	0.078	1.239 (0.976–1.574)
Off periods duration (MDS‐UPDRS Part IV‐3)	1.35	0.683	0.048*	3.859 (1.011–14.724)
Daytime dozing (Item15 of PDSS)	−0.244	0.155	0.115	0.783 (0.578–1.061)

Note: Multivariate logistic regression analysis using the forward stepwise selection method; with decision to continue apomorphine as a response variable and severity of insomnia, Off periods duration, painful Off dystonia, age, nocturnal restlessness, nocturia, daytime dozing as predictive variables. β: partial regression coefficient; OR (EXP [β]). Odds Ratio value of the corresponding variable with 95% Confidence Interval. In bold: P < 0.05.

Abbreviation: MDS‐UPDRS, Movement Disorder Society Unified Parkinson's Disease Rating Scale.